INPP1
Basic information
Region (hg38): 2:190343570-190371665
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the INPP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 13 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 1 | 1 |
Variants in INPP1
This is a list of pathogenic ClinVar variants found in the INPP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-190360154-A-G | not specified | Uncertain significance (May 26, 2024) | ||
2-190360158-C-T | not specified | Uncertain significance (Apr 25, 2022) | ||
2-190360171-AC-A | Retinal disorder;Cleft palate | Uncertain significance (-) | ||
2-190360201-C-T | Benign (Mar 30, 2018) | |||
2-190360253-A-T | not specified | Uncertain significance (Jan 16, 2024) | ||
2-190366729-G-T | not specified | Uncertain significance (Nov 19, 2022) | ||
2-190366848-A-G | not specified | Uncertain significance (Apr 08, 2024) | ||
2-190366854-A-G | not specified | Likely benign (May 27, 2022) | ||
2-190366869-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
2-190369216-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
2-190369222-C-T | not specified | Uncertain significance (Sep 23, 2023) | ||
2-190370864-G-C | not specified | Uncertain significance (Feb 23, 2023) | ||
2-190370891-T-C | not specified | Uncertain significance (Mar 28, 2023) | ||
2-190370926-G-A | not specified | Likely benign (Mar 15, 2024) | ||
2-190370965-G-T | not specified | Uncertain significance (Dec 14, 2023) | ||
2-190371047-A-C | not specified | Uncertain significance (Jan 10, 2023) | ||
2-190371082-A-C | not specified | Uncertain significance (May 27, 2022) | ||
2-190371142-A-C | not specified | Uncertain significance (Dec 07, 2021) | ||
2-190371213-C-G | not specified | Uncertain significance (Dec 01, 2022) | ||
2-190371252-G-T | not specified | Uncertain significance (Mar 21, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
INPP1 | protein_coding | protein_coding | ENST00000392329 | 5 | 28196 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.90e-7 | 0.508 | 125547 | 1 | 199 | 125747 | 0.000796 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.18 | 168 | 217 | 0.774 | 0.0000108 | 2600 |
Missense in Polyphen | 60 | 87.279 | 0.68745 | 1120 | ||
Synonymous | 0.728 | 73 | 81.3 | 0.897 | 0.00000408 | 795 |
Loss of Function | 0.808 | 11 | 14.3 | 0.769 | 6.97e-7 | 180 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000692 | 0.000690 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000416 | 0.000416 |
European (Non-Finnish) | 0.00123 | 0.00123 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000819 | 0.000817 |
Other | 0.00115 | 0.00114 |
dbNSFP
Source:
- Pathway
- Inositol phosphate metabolism - Homo sapiens (human);Phosphatidylinositol signaling system - Homo sapiens (human);Inositol Phosphate Metabolism;Inositol Metabolism;superpathway of D-<i>myo</i>-inositol (1,4,5)-trisphosphate metabolism;Inositol phosphate metabolism;D-<i>myo</i>-inositol (1,4,5)-trisphosphate degradation;Metabolism;Inositol phosphate metabolism;Synthesis of IP2, IP, and Ins in the cytosol
(Consensus)
Recessive Scores
- pRec
- 0.141
Intolerance Scores
- loftool
- 0.714
- rvis_EVS
- 0.13
- rvis_percentile_EVS
- 63
Haploinsufficiency Scores
- pHI
- 0.145
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.457
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.929
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Inpp1
- Phenotype
- hematopoietic system phenotype; immune system phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- phosphate-containing compound metabolic process;signal transduction;inositol phosphate metabolic process;phosphatidylinositol phosphorylation;inositol phosphate dephosphorylation
- Cellular component
- cytosol
- Molecular function
- inositol-1,4-bisphosphate 1-phosphatase activity;protein binding;metal ion binding;inositol-1,3,4-trisphosphate 1-phosphatase activity